Celastrol nano-emulsions selectively regulate apoptosis of synovial macrophage for alleviating rheumatoid arthritis

References

• Croia C, Bursi R, Sutera D, et al. One year in review 2019: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2019;37(3):347–357.
   PubMed Web of Science ®Google Scholar
• Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8(11):656–664. doi: 10.1038/nrrheum.2012.153.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS. Advances in the treatment of rheumatoid arthritis: costs and challenges. N C Med J. 2017;78(5):337–340. doi: 10.18043/ncm.78.5.337.
   PubMedGoogle Scholar
• Mustafa SH, Ahmad T, Balouch M, et al. Safety profile of methotrexate therapy in patients with rheumatoid arthritis. Cureus. 2022;14(7):e27047. doi: 10.7759/cureus.27047.
   PubMed Web of Science ®Google Scholar
• Wang D, Goldring SR. The bone, the joints and the Balm of Gilead. Mol Pharm. 2011;8(4):991–993. doi: 10.1021/mp200328t.
   PubMedGoogle Scholar
• Yang M, Feng X, Ding J, et al. Nanotherapeutics relieve rheumatoid arthritis. J Control Release. 2017;252:108–124. doi: 10.1016/j.jconrel.2017.02.032.
   PubMed Web of Science ®Google Scholar
• Han Y, Huang S. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy. J Control Release. 2023;356:142–161. doi: 10.1016/j.jconrel.2023.02.035.
   PubMed Web of Science ®Google Scholar
• Kim DK, Park JY, Kang YJ, et al. Drug repositioning of metformin encapsulated in PLGA combined with photothermal therapy ameliorates rheumatoid arthritis. Int J Nanomedicine. 2023;18:7267–7285. doi: 10.2147/IJN.S438388.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang Z, Wang F, et al. Reversible zwitterionic coordination enables rapid, high-yield, and high-purity isolation of extracellular vesicles from biofluids. Sci Adv. 2023;9(15):eadf4568. doi: 10.1126/sciadv.adf4568.
   PubMed Web of Science ®Google Scholar
• Kennedy A, Fearon U, Veale DJ, et al. Macrophages in synovial inflammation. Front Immunol. 2011;2:52. doi: 10.3389/fimmu.2011.00052.
   PubMed Web of Science ®Google Scholar
• Croft AP, Campos J, Jansen K, et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature. 2019;570(7760):246–251. doi: 10.1038/s41586-019-1263-7.
   PubMed Web of Science ®Google Scholar
• Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016;12(8):472–485. doi: 10.1038/nrrheum.2016.91.
   PubMed Web of Science ®Google Scholar
• Davignon JL, Hayder M, Baron M, et al. Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Rheumatology. 2013;52(4):590–598. doi: 10.1093/rheumatology/kes304.
   PubMed Web of Science ®Google Scholar
• Perlman H, Liu H, Georganas C, et al. Differential expression pattern of the antiapoptotic proteins, bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum. 2001;44(12):2899–2908. doi: 10.1002/1529-0131(200112)44:12<2899::AID-ART478>3.0.CO;2-X.
   PubMed Web of Science ®Google Scholar
• Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol. 2002;2(7):527–535. doi: 10.1038/nri846.
   PubMed Web of Science ®Google Scholar
• Williams B, Dharmapatni A, Crotti T. Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis. Inflamm Res. 2018;67(3):219–231. doi: 10.1007/s00011-017-1116-5.
   PubMed Web of Science ®Google Scholar
• Xu K, Xu P, Yao JF, et al. Reduced apoptosis correlates with enhanced autophagy in synovial tissues of rheumatoid arthritis. Inflamm Res. 2013;62(2):229–237. doi: 10.1007/s00011-012-0572-1.
   PubMed Web of Science ®Google Scholar
• Mountz JD, Zhang HG. Regulation of apoptosis of synovial fibroblasts. Curr Dir Autoimmun. 2001;3:216–239. doi: 10.1159/000060524.
   PubMedGoogle Scholar
• Canton J, Neculai D, Grinstein S. Scavenger receptors in homeostasis and immunity. Nat Rev Immunol. 2013;13(9):621–634. doi: 10.1038/nri3515.
   PubMed Web of Science ®Google Scholar
• Heo R, You DG, Um W, et al. Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. Biomaterials. 2017;131:15–26. doi: 10.1016/j.biomaterials.2017.03.044.
   PubMed Web of Science ®Google Scholar
• Dai Q, Zhou D, Xu L, et al. Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. Drug Des Devel Ther. 2018;12:4095–4105. doi: 10.2147/DDDT.S175763.
   PubMed Web of Science ®Google Scholar
• Kannaiyan R, Shanmugam MK, Sethi G. Molecular targets of celastrol derived from thunder of god vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett. 2011;303(1):9–20. doi: 10.1016/j.canlet.2010.10.025.
   PubMed Web of Science ®Google Scholar
• Que H, Hong W, Lan T, et al. Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal Transduct Target Ther. 2022;7(1):399. doi: 10.1038/s41392-022-01283-6.
   PubMed Web of Science ®Google Scholar
• Xu H, Zhao H, Ding C, et al. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduct Target Ther. 2023;8(1):51. doi: 10.1038/s41392-022-01231-4.
   PubMed Web of Science ®Google Scholar
• de Seabra Rodrigues Dias IR, Lo HH, Zhang K, et al. Potential therapeutic compounds from traditional Chinese medicine targeting endoplasmic reticulum stress to alleviate rheumatoid arthritis. Pharmacol Res. 2021;170:105696. doi: 10.1016/j.phrs.2021.105696.
   PubMed Web of Science ®Google Scholar
• Ren B, Liu H, Gao H, et al. Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR. Oncotarget. 2017;8(54):93039–93050. doi: 10.18632/oncotarget.21750.
   PubMedGoogle Scholar
• Gong T, Tan T, Zhang P, et al. Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis. Biomaterials. 2020;258:120296. doi: 10.1016/j.biomaterials.2020.120296.
   PubMed Web of Science ®Google Scholar
• Gong T, Zhang P, Deng C, et al. An effective and safe treatment strategy for rheumatoid arthritis based on human serum albumin and Kolliphor® HS 15. Nanomedicine. 2019;14(16):2169–2187. doi: 10.2217/nnm-2019-0110.
   PubMed Web of Science ®Google Scholar
• Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 2012;51(Suppl. 5):v3–v11. doi: 10.1093/rheumatology/kes113.
   PubMed Web of Science ®Google Scholar
• Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344(12):907–916. doi: 10.1056/NEJM200103223441207.
   PubMed Web of Science ®Google Scholar
• Chen J, Chen J, Tan J, et al. HIF-1alpha dependent RhoA as a novel therapeutic target to regulate rheumatoid arthritis fibroblast-like synoviocytes migration in vitro and in vivo. J Orthop Translat. 2023;40:49–57. doi: 10.1016/j.jot.2023.05.004.
   PubMed Web of Science ®Google Scholar
• van Tuyl LH, Voskuyl AE, Boers M, et al. Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Ann Rheum Dis. 2010;69(9):1623–1628. doi: 10.1136/ard.2009.121764.
   PubMed Web of Science ®Google Scholar